ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 161 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2018. The put-call ratio across all filers is 3.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $18,423,000 | +221.5% | 254,704 | +192.7% | 0.37% | +243.1% |
| Q4 2017 | $5,730,000 | +119.9% | 87,029 | +67.4% | 0.11% | +147.7% |
| Q3 2017 | $2,606,000 | -86.2% | 51,997 | -95.3% | 0.04% | -73.8% |
| Q1 2016 | $18,863,000 | -19.6% | 1,115,467 | +5.8% | 0.17% | -10.6% |
| Q4 2015 | $23,472,000 | +34.7% | 1,054,452 | +42.7% | 0.19% | +31.5% |
| Q3 2015 | $17,431,000 | -60.6% | 738,911 | +36.6% | 0.14% | -54.3% |
| Q2 2015 | $44,241,000 | +93.3% | 541,114 | +118.9% | 0.31% | +100.6% |
| Q1 2015 | $22,890,000 | +9129.8% | 247,195 | +3930.6% | 0.16% | +7700.0% |
| Q4 2014 | $248,000 | – | 6,133 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,629,835 | $116,685,000 | 25.08% |
| Aviva Holdings Ltd. | 1,200,100 | $53,248,000 | 14.21% |
| Boxer Capital, LLC | 1,375,000 | $61,009,000 | 6.77% |
| BB BIOTECH AG | 3,282,964 | $145,665,000 | 3.86% |
| Rhenman & Partners Asset Management AB | 353,961 | $15,705,000 | 1.57% |
| PFM Health Sciences, LP | 1,970,134 | $87,415,000 | 1.28% |
| Bellevue Group AG | 391,852 | $17,386,000 | 1.10% |
| Pentwater Capital Management LP | 2,351,500 | $104,336,000 | 0.88% |
| Partner Investment Management, L.P. | 25,440 | $1,129,000 | 0.86% |
| SABBY MANAGEMENT, LLC | 100,369 | $4,453,000 | 0.57% |